These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12939515)

  • 21. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
    Schunck WH; Konkel A; Fischer R; Weylandt KH
    Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docosahexaenoic acid, but not eicosapentaenoic acid, lowers ambulatory blood pressure and shortens interval QT in spontaneously hypertensive rats in vivo.
    Rousseau-Ralliard D; Moreau D; Guilland JC; Raederstorff D; Grynberg A
    Prostaglandins Leukot Essent Fatty Acids; 2009; 80(5-6):269-77. PubMed ID: 19428232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.
    Darwesh AM; Sosnowski DK; Lee TY; Keshavarz-Bahaghighat H; Seubert JM
    Chem Biol Interact; 2019 Aug; 308():20-44. PubMed ID: 31067438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.
    O'Connell TD; Block RC; Huang SP; Shearer GC
    J Mol Cell Cardiol; 2017 Feb; 103():74-92. PubMed ID: 27986444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. n-3 Polyunsaturated Fatty Acids Reduce Neonatal Hypoxic/Ischemic Brain Injury by Promoting Phosphatidylserine Formation and Akt Signaling.
    Zhang W; Liu J; Hu X; Li P; Leak RK; Gao Y; Chen J
    Stroke; 2015 Oct; 46(10):2943-50. PubMed ID: 26374481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.
    Zhang R; He GZ; Wang YK; Zhou KG; Ma EL
    Nutrition; 2015 Mar; 31(3):508-14. PubMed ID: 25701342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential effects of EPA and DHA on cardiovascular risk factors.
    Cottin SC; Sanders TA; Hall WL
    Proc Nutr Soc; 2011 May; 70(2):215-31. PubMed ID: 21349231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. n-3 PUFAs and cardiovascular disease prevention.
    Manerba A; Vizzardi E; Metra M; Dei Cas L
    Future Cardiol; 2010 May; 6(3):343-50. PubMed ID: 20462340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of serum phospholipid PUFAs with cardiometabolic risk: beneficial effect of DHA on the suppression of vascular proliferation/inflammation.
    Song J; Kwon N; Lee MH; Ko YG; Lee JH; Kim OY
    Clin Biochem; 2014 Apr; 47(6):361-8. PubMed ID: 24457065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?
    Song C; Shieh CH; Wu YS; Kalueff A; Gaikwad S; Su KP
    Prog Lipid Res; 2016 Apr; 62():41-54. PubMed ID: 26763196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.
    Saini RK; Keum YS
    Life Sci; 2018 Jun; 203():255-267. PubMed ID: 29715470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion.
    Khalfoun B; Thibault G; Bardos P; Lebranchu Y
    Transplantation; 1996 Dec; 62(11):1649-57. PubMed ID: 8970622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
    Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
    Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polyunsaturated fatty acids omega-3 as modulators of intracellular signaling pathways].
    Duda MK
    Postepy Biochem; 2012; 58(2):149-54. PubMed ID: 23214138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
    Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
    Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotection by omega-3 fatty acids: involvement of PKCs?
    Le Guennec JY; Jude S; Besson P; Martel E; Champeroux P
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):173-7. PubMed ID: 20189372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 fatty acids in cardiovascular disease--an uphill battle.
    von Schacky C
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jan; 92():41-7. PubMed ID: 24935800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.
    Li H; Ruan XZ; Powis SH; Fernando R; Mon WY; Wheeler DC; Moorhead JF; Varghese Z
    Kidney Int; 2005 Mar; 67(3):867-74. PubMed ID: 15698426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.